| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2265.1994.TB03929.X |
| P698 | PubMed publication ID | 7514512 |
| P2093 | author name string | E Nieschlag | |
| H M Behre | |||
| J Bohmeyer | |||
| P433 | issue | 3 | |
| P304 | page(s) | 341-349 | |
| P577 | publication date | 1994-03-01 | |
| P1433 | published in | Clinical Endocrinology | Q15762781 |
| P1476 | title | Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls | |
| P478 | volume | 40 |
| Q41544214 | Age-related changes in male gonadal function. Implications for therapy |
| Q34207540 | An update on male hypogonadism therapy |
| Q34707306 | Androgen deficiency and the aging male: new urologic perspectives |
| Q35207774 | Androgen deficiency in the aging male: benefits and risks of androgen supplementation |
| Q34707323 | Androgen deficiency in the aging male: pathophysiology, diagnosis, and treatment alternatives |
| Q37836264 | Androgen regulation of prostate cancer: where are we now? |
| Q42908268 | Androgen replacement therapy after prostate cancer treatment |
| Q34695715 | Androgen replacement therapy and prostate safety |
| Q35871132 | Androgen replacement therapy: present and future |
| Q53341836 | Androgen supplementation and prostate cancer risk: strategies for pretherapy assessment and monitoring. |
| Q33637744 | Androgen therapy in AIDS wasting |
| Q35567346 | Androgen therapy in the aging male |
| Q27010093 | Androgens and prostate disease |
| Q35145586 | Androgens and the ageing male and female |
| Q73476975 | Andropause |
| Q28352150 | Andropause. Testosterone replacement therapy for aging men |
| Q38181426 | Benign prostatic hyperplasia: a new metabolic disease? |
| Q50612224 | Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. |
| Q92358678 | Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis |
| Q35204823 | Declining testicular function in aging men. |
| Q37883014 | Differing levels of testosterone and the prostate: a physiological interplay |
| Q34622506 | Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial |
| Q35964540 | Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy. |
| Q44181120 | Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome |
| Q36935566 | Effects of Transdermal Testosterone Gel or an Aromatase Inhibitor on Prostate Volume in Older Men |
| Q77917193 | Endocrine aspects of ageing in the male |
| Q43637235 | Hormonal erectile dysfunction. Evaluation and management |
| Q33569163 | Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? |
| Q33895560 | Hormone substitution in male hypogonadism |
| Q34245288 | Hypogonadism and androgen replacement therapy in elderly men. |
| Q35539874 | Late-onset hypogonadism syndrome and lower urinary tract symptoms. |
| Q37872647 | Male hormonal contraception: potential risks and benefits |
| Q77919890 | Male hormone replacement therapy including "andropause" |
| Q28300144 | Male hypogonadism |
| Q35692900 | Male hypogonadism in the primary care clinic |
| Q35117241 | Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan |
| Q34760746 | Molecular mechanisms of bladder outlet obstruction in transgenic male mice overexpressing aromatase (Cyp19a1). |
| Q34381014 | Neuroendocrine abnormalities associated with HIV infection |
| Q34380984 | Neuroendocrine aging in men. Andropause and somatopause |
| Q37900796 | Onset of effects of testosterone treatment and time span until maximum effects are achieved |
| Q33637793 | Potential adverse effects of long-term testosterone therapy |
| Q47315208 | Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system |
| Q79293758 | Prostatic volume in young adults after treatment of cryptorchidism in childhood |
| Q37686901 | Quality of Life and Sexual Health in the Aging of PCa Survivors |
| Q37498164 | Risks of testosterone replacement therapy in men. |
| Q33737427 | Risks versus benefits of testosterone therapy in elderly men. |
| Q37057953 | Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone |
| Q38822099 | Testosterone Deficiency and the Prostate. |
| Q26863719 | Testosterone and benign prostatic hyperplasia |
| Q45059435 | Testosterone and the prostate |
| Q46300492 | Testosterone and the prostate: implications for the treatment of hypogonadal men. |
| Q37069021 | Testosterone depot injection in male hypogonadism: a critical appraisal |
| Q46913725 | Testosterone replacement therapy and prostate cancer |
| Q47215640 | Testosterone replacement therapy and prostate health |
| Q36310652 | Testosterone replacement therapy and the risk of prostate cancer. Is there a link? |
| Q36271731 | Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents |
| Q35195115 | Testosterone replacement therapy in male hypogonadism |
| Q33913912 | Testosterone therapy in men: clinical and pharmacological perspectives |
| Q55427313 | Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels. |
| Q35947451 | Testosterone treatment for the aging man: the controversy |
| Q40472407 | The Aging Male Reproductive System |
| Q35855052 | The Relationship Between Testosterone-Replacement Therapy and Lower Urinary Tract Symptoms: A Systematic Review |
| Q36993669 | The role of testosterone replacement therapy following radical prostatectomy |
| Q38032318 | Topical testosterone supplementation for the treatment of male hypogonadism |
| Q41722677 | Transdermal testosterone |
| Q38528376 | Update on Testosterone Replacement Therapy in Hypogonadal Men. |
| Q35070763 | Urologic aspects of andropause |
Search more.